4.6 Article

Human Cytomegalovirus Gene UL21a Encodes a Short-Lived Cytoplasmic Protein and Facilitates Virus Replication in Fibroblasts

Journal

JOURNAL OF VIROLOGY
Volume 84, Issue 1, Pages 291-302

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.01116-09

Keywords

-

Categories

Funding

  1. NCI NIH HHS [CA-120768, R01 CA120768] Funding Source: Medline
  2. NIAID NIH HHS [T32 AI007172, T32-AI007172] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [R01CA120768] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The human cytomegalovirus (HCMV) gene UL21a was recently annotated by its conservation in chimpanzee cytomegalovirus. Two large-scale mutagenic analyses showed that mutations in overlapping UL21a/UL21 resulted in a severe defect of virus growth in fibroblasts. Here, we characterized UL21a and demonstrated its role in HCMV infection. We mapped a UL21a-specific transcript of similar to 600 bp that was expressed with early kinetics. UL21a encoded pUL21a, a protein of similar to 15 kDa, which was unstable and localized predominantly to the cytoplasm during HCMV infection or when expressed alone. Interestingly, pUL21a was drastically stabilized in the presence of proteasome inhibitor MG132, but its instability was independent of a functional ubiquitin-mediated pathway, suggesting that pUL21a underwent proteasome-dependent, ubiquitin-independent degradation. A UL21a deletion virus was attenuated in primary human newborn foreskin fibroblasts (HFFs) and embryonic lung fibroblasts (MRC-5), whereas a marker-rescued virus and mutant viruses lacking the neigh-boring or overlapping genes UL20, UL21, or UL21.5-UL23 replicated at wild-type levels. The growth defect of UL21a-deficient virus in MRC-5 cells was more pronounced than that in HFFs. At a high multiplicity of infection, the UL21a deletion virus synthesized viral proteins with wild-type kinetics but had a two-to threefold defect in viral DNA replication. More importantly, although pUL21a was not detected in the virion, progeny virions produced by the mutant virus were similar to 10 times less infectious than wild-type virus, suggesting that UL21a is required for HCMV to establish efficient productive infection. We conclude that UL21a encodes a short-lived cytoplasmic protein and facilitates HCMV replication in fibroblasts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Virology

The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation

Yousef M. O. Alhammad, Anthony R. Fehr

VIRUSES-BASEL (2020)

Article Biochemistry & Molecular Biology

Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity

Collin D. Heer, Daniel J. Sanderson, Lynden S. Voth, Yousef M. O. Alhammad, Mark S. Schmidt, Samuel A. J. Trammell, Stanley Perlman, Michael S. Cohen, Anthony R. Fehr, Charles Brenner

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Virology

Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication

Lynden S. Voth, Joseph J. O'Connor, Catherine M. Kerr, Ethan Doerger, Nancy Schwarting, Parker Sperstad, David K. Johnson, Anthony R. Fehr

Summary: The macrodomain Mac1 within nonstructural protein 3 of coronaviruses has been identified as essential for viral replication, with targeted mutations revealing multiple functions that contribute to the replication of the model CoV MHV. These findings suggest that Mac1 may be a potential target for anti-CoV therapeutics.

JOURNAL OF VIROLOGY (2021)

Article Biochemistry & Molecular Biology

ADP-ribosyltransferases, an update on function and nomenclature

Bernhard Luscher, Ivan Ahel, Matthias Altmeyer, Alan Ashworth, Peter Bai, Paul Chang, Michael Cohen, Daniela Corda, Francoise Dantzer, Matthew D. Daugherty, Ted M. Dawson, Valina L. Dawson, Sebastian Deindl, Anthony R. Fehr, Karla L. H. Feijs, Dmitri V. Filippov, Jean-Philippe Gagne, Giovanna Grimaldi, Sebastian Guettler, Nicolas C. Hoch, Michael O. Hottiger, Patricia Korn, W. Lee Kraus, Andreas Ladurner, Lari Lehtio, Anthony K. L. Leung, Christopher J. Lord, Aswin Mangerich, Ivan Matic, Jason Matthews, George-Lucian Moldovan, Joel Moss, Gioacchino Natoli, Michael L. Nielsen, Mario Niepel, Friedrich Nolte, John Pascal, Bryce M. Paschal, Krzysztof Pawlowski, Guy G. Poirier, Susan Smith, Gyula Timinszky, Zhao-Qi Wang, Jose Yelamos, Xiaochun Yu, Roko Zaja, Mathias Ziegler

Summary: ADP-ribosylation, a post-translational modification of proteins, nucleic acids, and metabolites, plays diverse roles in cellular processes such as stress responses, signaling, and transcriptional regulation. Recent advances in research have identified a wide range of cellular pathways regulated by ADP-ribosylation, highlighting the importance of understanding this mechanism in cell biology.

FEBS JOURNAL (2022)

Article Biochemistry & Molecular Biology

High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain

Morgan Dasovich, Junlin Zhuo, Jack A. Goodman, Ajit Thomas, Robert Lyle McPherson, Aravinth Kumar Jayabalan, Veronica F. Busa, Shang-Jung Cheng, Brennan A. Murphy, Karli R. Redinger, Yousef M. O. Alhammad, Anthony R. Fehr, Takashi Tsukamoto, Barbara S. Slusher, Jurgen Bosch, Huijun Wei, Anthony K. L. Leung

Summary: Viral macrodomains are crucial for virus replication and pathogenesis, making them a promising target for antiviral therapy. Dasatinib has been identified as a potential ADP-ribosylhydrolase inhibitor, showing effectiveness against SARS-CoV-2 and MERS-CoV, but not affecting the closest human homologue MacroD2. This study demonstrates the feasibility of identifying selective inhibitors based on ADP-ribosylhydrolase activity and provides a potential avenue for developing better macrodomain inhibitors as antiviral therapies for SARS-CoV-2 and other viral threats.

ACS CHEMICAL BIOLOGY (2022)

Article Microbiology

The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses

Anthony K. L. Leung, Diane E. Griffin, Juergen Bosch, Anthony R. Fehr

Summary: Emerging and re-emerging viral diseases pose continuous threats to public health. Developing a diverse portfolio of antiviral agents is crucial for effective control. The macrodomain, a drug target critical for the replication and pathogenesis of alphaviruses and coronaviruses, has the potential to block virus replication and restore the host's protective interferon response. Macrodomain inhibitors, with their well-defined binding pocket, offer an attractive target for developing direct acting antivirals and complementing current approaches in combating COVID-19 and future viral threats.

PATHOGENS (2022)

Article Multidisciplinary Sciences

MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells

Courtney E. Comar, Clayton J. Otter, Jessica Pfannenstiel, Ethan Doerger, David M. Renner, Li Hui Tan, Stanley Perlman, Noam A. Cohen, Anthony R. Fehr, Susan R. Weiss

Summary: MERS-CoV optimizes its replication by suppressing early innate immune pathways, including interferon production and signaling, through the actions of endoribonuclease (EndoU) and accessory proteins NS4a and NS4b.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Pharmacology & Pharmacy

Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening

Anu Roy, Yousef M. Alhammad, Peter McDonald, David K. Johnson, Junlin Zhuo, Sarah Wazir, Dana Ferraris, Lari Lehtio, Anthony K. L. Leung, Anthony R. Fehr

Summary: This study focuses on screening for potential inhibitors of the SARS-CoV-2 conserved macrodomain (Mac1). Five compounds from three chemotypes were identified, which show inhibitory effects on Mac1-ADP-ribose binding, ADP-ribosylhydrolase activity, and direct Mac1 binding, making them strong candidates for the development of highly effective Mac1 inhibitors.

ANTIVIRAL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain

Lavinia M. Sherrill, Elva E. Joya, AnnMarie Walker, Anuradha Roy, Yousef M. Alhammad, Moriama Atobatele, Sarah Wazir, George Abbas, Patrick Keane, Junlin Zhuo, Anthony K. L. Leung, David K. Johnson, Lari Lehtio, Anthony R. Fehr, Dana Ferraris

Summary: A series of amino acid based compounds were designed and synthesized to investigate their inhibitory activity against the SARS-CoV-2 nsp3 macrodomain. Compound 15c was identified as a low-micromolar inhibitor and demonstrated selectivity for coronavirus macrodomains.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Article Microbiology

PARP14: A key ADP-ribosylating protein in host-virus interactions?

Srivatsan Parthasarathy, Anthony R. Fehr

Summary: The translation discusses the impact of posttranslational modifications (PTMs) on protein functions, focusing on the role of ADP-ribosylation. Specifically, it highlights the importance of PARP14, a MARylating enzyme, in anti-inflammatory and antiviral responses, while also emphasizing the need for further studies to elucidate its specific roles and mechanisms during viral infections.

PLOS PATHOGENS (2022)

Article Microbiology

Inhibitors of One or More Cellular Aurora Kinases Impair the Replication of Herpes Simplex Virus 1 and Other DNA and RNA Viruses with Diverse Genomes and Life Cycles

Cindy Y. Ly, Jessica Pfannenstiel, Anil Pant, Zhilong Yang, Anthony R. Fehr, Maxim S. Rodzkin, David J. Davido

Summary: In this study, aurora kinase inhibitors were found to significantly reduce gene expression and viral replication of herpes simplex virus 1 (HSV-1). Furthermore, these inhibitors also showed inhibitory effects on the replication of other RNA and DNA viruses. These findings suggest a novel role for aurora kinases in the replication of diverse viruses.

MICROBIOLOGY SPECTRUM (2023)

Article Virology

PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner

Catherine M. Kerr, Srivatsan Parthasarathy, Nancy Schwarting, Joseph J. O'Connor, Jessica J. Pfannenstiel, Emily Giri, Sunil More, Robin C. Orozco, Anthony R. Fehr

Summary: PARP12 is an important mediator of the antiviral response to coronaviruses, but additional PARPs or innate immune factors contribute to virus attenuation in mice. PARP12 knockout increases Mac1 mutant virus replication and liver pathology in mice.

JOURNAL OF VIROLOGY (2023)

Article Microbiology

Two Commercially Available Blood-Stabilization Reagents Serve as Potent Inactivators of Coronaviruses

Joseph J. O'Connor, Lynden Voth, Jeremiah Athmer, Nicholas M. George, Christopher M. Connelly, Anthony R. Fehr

Summary: Testing two commercially available blood collection tube blood-stabilization reagents, cfDNA and CytoChex, it was found that they can rapidly inactivate coronaviruses and effectively preserve viral RNA stability for a certain period of time.

PATHOGENS (2023)

Review Microbiology

An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors

Joseph J. O'Connor, Dana Ferraris, Anthony R. Fehr

Summary: This article summarizes the progress in the search for inhibitors of the SARS-CoV-2 Mac1 protein. Various unique chemical inhibitors have been successfully created using high-throughput screening and chemical modifications.

PATHOGENS (2023)

Article Virology

The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase

Yousef M. O. Alhammad, Maithri M. Kashipathy, Anuradha Roy, Jean-Philippe Gagne, Peter McDonald, Philip Gao, Louis Nonfoux, Kevin P. Battaile, David K. Johnson, Erik D. Holmstrom, Guy G. Poirier, Scott Lovell, Anthony R. Fehr

Summary: The Mac1 proteins in SARS-CoV-2 and other CoVs are MAR-hydrolases with similar functions, suggesting compounds targeting these proteins may have broad anti-CoV activity. Understanding the biochemistry and enzyme activity of these proteins is critical for developing novel therapeutic strategies against COVID-19.

JOURNAL OF VIROLOGY (2021)

No Data Available